Developing aptamers into therapeutics.
Publication
, Journal Article
White, RR; Sullenger, BA; Rusconi, CP
Published in: J Clin Invest
October 2000
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Invest
DOI
ISSN
0021-9738
Publication Date
October 2000
Volume
106
Issue
8
Start / End Page
929 / 934
Location
United States
Related Subject Headings
- Tunica Intima
- Technology, Pharmaceutical
- Oligonucleotides
- Nucleic Acids
- Neovascularization, Physiologic
- Immunology
- Drug Design
- Combinatorial Chemistry Techniques
- Blood Coagulation
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
White, R. R., Sullenger, B. A., & Rusconi, C. P. (2000). Developing aptamers into therapeutics. J Clin Invest, 106(8), 929–934. https://doi.org/10.1172/JCI11325
White, R. R., B. A. Sullenger, and C. P. Rusconi. “Developing aptamers into therapeutics.” J Clin Invest 106, no. 8 (October 2000): 929–34. https://doi.org/10.1172/JCI11325.
White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clin Invest. 2000 Oct;106(8):929–34.
White, R. R., et al. “Developing aptamers into therapeutics.” J Clin Invest, vol. 106, no. 8, Oct. 2000, pp. 929–34. Pubmed, doi:10.1172/JCI11325.
White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clin Invest. 2000 Oct;106(8):929–934.
Published In
J Clin Invest
DOI
ISSN
0021-9738
Publication Date
October 2000
Volume
106
Issue
8
Start / End Page
929 / 934
Location
United States
Related Subject Headings
- Tunica Intima
- Technology, Pharmaceutical
- Oligonucleotides
- Nucleic Acids
- Neovascularization, Physiologic
- Immunology
- Drug Design
- Combinatorial Chemistry Techniques
- Blood Coagulation
- 42 Health sciences